Eugene P. Kennedy - 25 Feb 2023 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Medical Officer
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Eugene P. Kennedy
Issuer symbol
GRTX
Transactions as of
25 Feb 2023
Net transactions value
$0
Form type
4
Filing time
28 Feb 2023, 17:57:34 UTC
Previous filing
02 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +55,000 $0.000000 55,000 25 Feb 2023 Common Stock 55,000 $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023.